Can patients with severe renal failure use ARB medications?

ARB refers to angiotensin receptor blockers. Patients with severe renal failure generally are not advised to use angiotensin receptor blockers. If there are any concerns, it is recommended to seek medical advice in advance. Detailed analysis is as follows:

Angiotensin receptor blockers are a type of antihypertensive medication that lower blood pressure by blocking the receptors of angiotensin II, thereby dilating blood vessels. They also offer protective effects on the cardiovascular system and kidneys. However, in patients with severe renal failure, kidney function is already severely impaired, significantly reducing the body's ability to excrete metabolic waste and toxins. Using angiotensin receptor blockers may further increase the burden on the kidneys.

In addition, angiotensin receptor blockers may cause elevated levels of serum creatinine and potassium. In patients with severe renal failure, the kidneys are already unable to effectively eliminate these substances, potentially leading to serious complications such as hyperkalemia. Patients with severe renal failure often require dialysis to sustain life. During dialysis, the patient's blood pressure and hemodynamic status may fluctuate, further increasing the uncertainty regarding the use of ARB medications.

Patients with severe renal failure must not self-administer medications or alter their treatment plans, to avoid worsening the condition or triggering complications.